¶ Hypothalamic POMC and CART Neurons
Proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) neurons in the hypothalamic arcuate nucleus constitute the primary anorexigenic (appetite-suppressing) neural population in the central nervous system. These neurons serve as the central processors of metabolic signals, integrating information about energy stores, food availability, and nutritional status to coordinate feeding behavior, energy expenditure, and glucose homeostasis [@cowley2001]. The melanocortin system, centered on POMC neurons, represents one of the most important and evolutionarily conserved pathways for energy balance regulation, with direct relevance to neurodegenerative diseases that affect metabolic function.
POMC neurons produce a variety of bioactive peptides through tissue-specific processing, including α-melanocyte-stimulating hormone (α-MSH), adrenocorticotropic hormone (ACTH), and β-endorphin. These peptides act through melanocortin receptors (MCRs) in downstream brain regions to suppress food intake and increase energy expenditure [@cone2005]. CART neurons, which are often co-localized with POMC neurons, provide additional anorexigenic signaling and project widely throughout the brain and spinal cord [@elias1998].
The functional integrity of POMC/CART neurons is essential for normal metabolic regulation, and dysfunction in these neurons contributes to obesity, diabetes, and metabolic disturbances observed in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD). Understanding the biology of these neurons is therefore critical for understanding the metabolic components of neurodegeneration.
¶ POMC Gene and Peptide Processing
¶ Gene Structure and Expression
The POMC gene (chromosome 2p23.3) encodes a 267-amino acid precursor polypeptide that undergoes extensive tissue-specific post-translational processing [@zhang1994]:
Expression Sites:
- Anterior pituitary (corticotropes)
- Intermediate pituitary (melanotropes)
- Hypothalamic arcuate nucleus
- Nucleus tractus solitarius (NTS)
- Skin melanocytes
- Immune cells (lymphocytes, macrophages)
Transcription Factors:
- POU1F1 (pituitary-specific)
- T-Pit (Tbx19 for corticotrope lineage)
- NeuroD1 (neuronal expression)
- ISL1 (lim homeobox)
POMC is processed by prohormone convertases (PC1/3 and PC2) into diverse bioactive peptides:
| Precursor |
Enzyme |
Product |
Function |
| POMC |
PC1/3 |
ACTH |
Adrenal stimulation |
| ACTH |
PC2 |
CLIP |
Unknown |
| ACTH |
PC1/3 |
α-MSH |
Melanocortin receptor binding |
| β-LPH |
PC1/3 |
β-MSH |
Appetite regulation |
| β-LPH |
PC2 |
β-Endorphin |
Opioid effects |
| γ-MSH |
From N-terminal |
Energy balance |
|
The melanocortin peptide family includes:
- α-MSH: Primary anorexigenic melanocortin
- β-MSH: Energy homeostasis
- γ-MSH: Adrenal regulation
- ACTH: Adrenal cortex stimulation
- β-Endorphin: Opioid receptor binding
¶ Gene and Expression
The CART (SLC15A5) gene encodes a protein that was originally identified as being upregulated by cocaine and amphetamine in the striatum [@kimmel1998]:
Expression Sites:
- Hypothalamic arcuate nucleus (co-localized with POMC)
- Lateral hypothalamus
- Dorsal raphe nucleus
- Spinal cord dorsal horn
- Peripheral tissues (pancreas, adrenal gland)
CART exists in multiple forms:
- CART(1-102): Full-length form
- CART(1-77): Major brain form
- CART(4-73): Biological active fragment
CART signals through multiple mechanisms:
- GPCR-mediated: Putative CART receptors
- Intracellular signaling: MAPK pathways
- Synaptic modulation: Neurotransmitter release
POMC/CART neurons reside in the arcuate nucleus (ARC), also known as the infundibular nucleus [@schwartz2000]:
Location:
- Median eminence (ventral)
- Third ventricle (medial)
- Superior to the median eminence
- Periventricular zone
Cellular Organization:
- Medial region: POMC/CART predominates
- Lateral region: NPY/AgRP predominates
- Overlap zone: Mixed populations
POMC neurons exhibit distinctive markers:
Marker Expression:
- POMC mRNA and peptide products
- CART peptide
- Cocaine- and amphetamine-regulated transcript
- Leptin receptor (LepRb)
- Glucose transporter (GLUT2)
- Proopiomelanocortin
Electrophysiological Properties:
- Leptin-responsive (depolarization)
- Glucose-responsive (excitation)
- GABAergic output
- Synaptic inputs from multiple brain regions
Leptin, the adipocyte-derived satiety hormone, directly activates POMC neurons [@belgardt2010]:
Leptin Receptor Signaling:
- LepRb activation by leptin
- JAK2-STAT3 signaling pathway
- Phosphatidylinositol 3-kinase (PI3K) activation
- AMPK modulation
Electrophysiological Effects:
- Membrane depolarization
- Increased firing rate
- Reduced GABAergic input
- Enhanced excitatory drive
POMC neurons function as glucose-sensing neurons [@parton2007]:
Mechanisms:
- GLUT2 expression (detects extracellular glucose)
- ATP-sensitive potassium channels (KATP)
- AMPK activation during low glucose
- Calcium influx through voltage-gated channels
Metabolic Implications:
- Coordinated response to hypoglycemia
- Integration with leptin signaling
- Counter-regulatory hormone release
| Signal |
Effect on POMC |
Mechanism |
| Insulin |
Excitation |
PI3K signaling |
| Ghrelin |
Inhibition |
Orexigenic input |
| Serotonin |
Excitation |
5-HT2C receptor |
| NPY/AgRP |
Inhibition |
Synaptic GABA |
| Mechanical stretch |
Excitation |
Gut vagal afferents |
POMC/CART neurons project throughout the brain [@elias1998]:
Major Targets:
- Paraventricular nucleus (PVN): Appetite suppression
- Lateral hypothalamus (LH): Energy expenditure
- Preoptic area: Thermogenesis
- Dorsal raphe nucleus: Mood/affect
- Spinal cord: Autonomic control
- Nucleus tractus solitarius: Satiety signaling
The projections target neurons expressing melanocortin receptors [@cone2005]:
Receptor Subtypes:
- MC3R: Expressed in hypothalamus, involved in energy homeostasis
- MC4R: Expressed in PVN and limbic system, mediates appetite suppression
Downstream Effects:
- Reduced food intake
- Increased energy expenditure
- Enhanced glucose utilization
- Thermogenesis activation
POMC/CART neurons provide the primary anorexigenic signal in the hypothalamus [@morton2006]:
Feeding Suppression:
- α-MSH release activates MC3/4R
- Inhibits NPY/AgRP neurons
- Reduces food intake
- Promotes satiety
Meal Termination:
- Integration of gut-derived signals
- Post-absorptive signals
- Learned satiety mechanisms
Melanocortin signaling increases energy expenditure:
Thermoregulation:
- Brown adipose tissue activation
- Thermogenic gene expression
- Shivering thermogenesis
- Non-shivering thermogenesis
Locomotor Activity:
- Increased spontaneous activity
- Enhanced exploratory behavior
- Metabolic rate elevation
POMC neurons modulate glucose homeostasis:
Pancreatic Function:
- Regulation of insulin secretion
- β-cell mass maintenance
- Glucagon control
Hepatic Glucose Output:
- Suppression of gluconeogenesis
- Enhanced glycogen synthesis
- Insulin sensitivity
Metabolic disturbances commonly precede and accompany AD, with POMC/CART dysfunction playing a role [@caner2020]:
Pathophysiological Mechanisms:
-
Amyloid-β Effects:
- Direct toxicity to hypothalamic neurons
- Disruption of leptin signaling
- Impaired glucose sensing
-
Tau Pathology:
- Neurofibrillary tangle formation in hypothalamus
- Disruption of POMC neuron function
- Altered peptide processing
-
Metabolic Comorbidities:
- Leptin resistance
- Insulin resistance
- Dysregulated glucose homeostasis
Clinical Manifestations:
- Weight loss and cachexia in advanced AD
- Appetite disturbances
- Glucose intolerance
- Altered diurnal rhythms
Therapeutic Implications:
- Melanocortin receptor agonists
- Leptin replacement therapy
- Metabolic modulators
PD patients frequently experience weight loss and metabolic alterations linked to POMC/CART dysfunction:
Pathological Mechanisms:
-
Lewy Body Pathology:
- α-Synuclein deposition in hypothalamus
- Disruption of metabolic regulation
- Autonomic dysfunction
-
Dopaminergic Influence:
- Modulation of POMC neurons
- Altered reward signaling
- Gastrointestinal dysfunction
Clinical Features:
- Progressive weight loss
- Appetite suppression
- Sleep disturbances (REM behavior disorder)
- Autonomic failure
Treatment Considerations:
- Levodopa effects on metabolism
- Deep brain stimulation impacts
- Non-motor symptom management
The metabolic syndrome creates a pro-neurodegenerative environment:
Shared Mechanisms:
- Chronic inflammation
- Insulin resistance
- Oxidative stress
- Mitochondrial dysfunction
Bidirectional Relationships:
- Obesity increases AD/PD risk
- Neurodegeneration alters metabolism
- Shared inflammatory pathways
MC3/4R Agonists:
- Synthetic α-MSH analogs
- Non-peptide small molecule agonists
- Selective MC4R agonists
Clinical Applications:
- Obesity treatment
- Cachexia management
- Metabolic syndrome
Therapeutic Strategies:
- Recombinant leptin (metreleptin)
- Leptin sensitizers
- STAT3 pathway activators
Challenges:
- Leptin resistance in obesity
- Central access limitations
- Antibody development
Approaches:
- CART peptide administration
- CART receptor agonists
- Gene therapy approaches
¶ Gene Therapy and Cell-Based Approaches
Emerging Strategies:
- POMC neuron transplantation
- Gene editing for POMC mutations
- Induced neuron conversion
- CRISPR-based therapies
- Cowley et al., Leptin activates POMC neurons (2001)
- Cone, Anatomy and regulation of central melanocortin system (2005)
- Elias et al., Leptin activates hypothalamic CART neurons (1998)
- Zhang et al., Positional cloning of the mouse obese gene (1994)
- Schwartz et al., Central nervous system control of food intake (2000)
- Morton et al., CNS control of food intake and body weight (2006)
- Belgardt and Bruning, CNS leptin and insulin action (2010)
- Dietrich and Horvath, Hypothalamic POMC neurons (2012)
- Stanley et al., Hormonal regulation of food intake (2010)
- Williams et al., Spatial and temporal mapping of leptin signaling (2010)
- Parton et al., Glucose sensing by POMC neurons (2007)
- Claret et al., Deletion of CaMKK from POMC neurons (2007)
- Can et al., Hypothalamic POMC neurons in neurodegenerative diseases (2020)
- Ahima et al., Leptin regulation of neuroendocrine function (2000)
- Elias et al., Leptin differentially regulate NPY and POMC (1999)
- Kristensen et al., Hypothalamic CART regulates appetite (1998)
- Lee et al., Leptin and POMC neurons in metabolic regulation (2012)
- Schwartz, Integrative coding of food intake (2013)
- Bjornholm et al., Leptin signaling in energy homeostasis (2017)
- Shin et al., Feedback networks in hypothalamic energy balance (2017)